• KidneyIntelX testing technology has been included in the final KDIGO 2024 Clinical Practice Guidelines for the Evaluation and Management of CKD.


  • New published data demonstrates that EHR deployment of KidneyIntelX™ was associated with clinical actions that slowed progression of chronic kidney disease and improved Type 2 diabetes control in just 12 months. Results demonstrated a 61% increase in preventative drug prescriptions among patients in the high-risk group and improved specialist referrals which can significantly reduce overall cost of care and improve patient outcomes.